QUANTUM announced on August 5, 2025, from Toronto, that their CSR allowed the advancement of an IND application with the FDA.
1 report, 1 independent
Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
QUANTUM announced on August 5, 2025, from Toronto, that their CSR allowed the advancement of an IND application with the FDA.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
Coverage
Newest first; wire copies grouped- GlobeNewswireQuantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid